Congressional Trader
Live

NVS congressional trades

9 matched disclosures

Track congressional trades for NVS
Tracked disclosures
9
Lawmakers
3
Buy / sell
5 / 4
Avg post-trade move
N/A
Latest filing 2025-11-21

NVS congressional trades snapshot

This page summarizes public STOCK Act disclosures involving NVS. It is useful for seeing which lawmakers reported NVS transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Nov 21, 2025

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the NVS congressional trade page shows

Congressional Trader tracks 9 public STOCK Act disclosures for NVSacross 3 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent NVS filing shown here was filed on Nov 21, 2025 by Lisa C. McClain as a sale. Related lawmakers include Lisa C. McClain, George Whitesides, Sheldon Whitehouse.

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
No committee data
Filed Nov 21, 2025
Delay 21 days
View filing
Novartis AG Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Nov 21, 2025
Delay 22 days
View filing
NVSNotable
Novartis AG Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Nov 21, 2025
Delay 22 days
View filing
Novartis AG Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Oct 22, 2025
Delay 41 days
View filing
Novartis AG Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Aug 13, 2025
Delay 57 days
View filing
NVSNotable
Novartis AG Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Aug 13, 2025
Delay 63 days
View filing
Novartis AG Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Aug 13, 2025
Delay 65 days
View filing
Novartis AG Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Apr 23, 2025
Delay 30 days
View filing
Novartis AG Common Stock
Sale
$100K - $250K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 20, 2024
Delay 41 days
View filing
Novartis Ag ADR
Partial sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded NVS?

Recent NVS disclosures include Lisa C. McClain, George Whitesides, Sheldon Whitehouse.

What is the buy/sell mix for NVS?

The visible sample currently shows 5 purchases and 4 sales or partial sales.

Should I trade based on NVS disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.